2 Patents
- US121717832024Methods and Compositions for Targeting Developmental and Oncogenic Programs in H3K27M Gliomas
Dana-farber Cancer Institute, Inc.
0 cites - US120180802024Methods and Compositions for Treating Cancer by Targeting the CLEC2D-KLRB1 Pathway
Dana-farber Cancer Institute, Inc.
0 cites